Anika Therapeutics, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Anika Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2010 to Q2 2024.
  • Anika Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $844K.
  • Anika Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $220K.
  • Anika Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was -$2.66M, a 31.6% increase from 2022.
  • Anika Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was -$3.89M, a 128% decline from 2021.
  • Anika Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was -$1.71M, a 63.2% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $220K $844K +$1.17M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$953K $43K +$1.71M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$2.66M -$204K +$1.28M +86.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-15
Q3 2023 -$3.94M -$463K +$724K +61% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 -$4.66M -$329K +$113K +25.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$4.78M -$1.66M -$889K -115% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$3.89M -$1.48M +$1.89M +56.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-15
Q3 2022 -$5.78M -$1.19M -$1.88M -271% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 -$3.9M -$442K -$3.04M -117% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$859K -$775K +$848K +52.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$1.71M -$3.38M -$896K -36.1% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-15
Q3 2021 -$811K $694K +$2.44M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$3.25M $2.6M +$4.6M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$7.85M -$1.62M -$3.2M -203% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 -$4.64M -$2.48M -$3.59M -323% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-16
Q3 2020 -$1.05M -$1.74M -$5.08M -152% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $4.03M -$2M -$5.01M -166% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $9.04M $1.58M +$107K +7.26% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $8.93M $1.11M -$1.49M -57.2% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-11
Q3 2019 $10.4M $3.33M +$1.84M +123% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $8.58M $3.01M +$1.57M +109% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $7.01M $1.47M +$2.52M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-22
Q4 2018 $4.49M $2.6M +$797K +44.3% Oct 1, 2018 Dec 31, 2018 10-K/A 2021-04-26
Q3 2018 $3.69M $1.5M -$2.15M -58.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-28
Q2 2018 $5.84M $1.44M -$4.93M -77.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-26
Q1 2018 $10.8M -$1.05M -$3.62M -141% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-06
Q4 2017 $14.4M $1.8M -$2.91M -61.8% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-06
Q3 2017 $17.3M $3.64M -$1.19M -24.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-26
Q2 2017 $18.5M $6.37M +$1.47M +30% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-31
Q1 2017 $17M $2.57M -$1.32M -33.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $18.3M $4.7M -$1.36M -22.4% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 $19.7M $4.83M +$41K +0.86% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-27
Q2 2016 $19.6M $4.9M +$269K +5.81% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-28
Q1 2016 $19.4M $3.89M +$1.87M +93.1% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $17.5M $6.06M +$1.75M +40.5% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 $15.7M $4.79M +$664K +16.1% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-01
Q2 2015 $15.1M $4.63M -$1.27M -21.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-01
Q1 2015 $16.4M $2.01M -$6.83M -77.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-03
Q4 2014 $23.2M $4.31M +$556K +14.8% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-24
Q3 2014 $22.6M $4.13M +$1.35M +48.6% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-03
Q2 2014 $21.3M $5.91M +$2.44M +70.3% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-04
Q1 2014 $18.8M $8.84M +$6.94M +364% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-04
Q4 2013 $11.9M $3.76M +$472K +14.4% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-10
Q3 2013 $11.4M $2.78M +$1.74M +168% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 $9.69M $3.47M +$1.12M +47.7% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-04
Q1 2013 $8.57M $1.9M +$804K +73.1% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-05
Q4 2012 $7.77M $3.29M +$1.3M +65.7% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-13
Q3 2012 $6.47M $1.04M -$758K -42.3% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-05
Q2 2012 $7.22M $2.35M +$998K +74% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 $6.23M $1.1M +$908K +475% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-06
Q4 2011 $5.32M $1.98M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-13
Q3 2011 $1.79M +$941K +110% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 $1.35M +$672K +99.1% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
Q1 2011 $191K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-07
Q3 2010 $853K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 $678K Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.